Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
NSD2 mediates NF-κB and matrix metalloproteinases to drive hepatocellular carcinoma malignant progression.
Journal: Translational cancer research
Published: April 15, 2025
Matrin-3 acts as a potential biomarker and promotes hepatocellular carcinoma progression by interacting with cell cycle-regulating genes.
Journal: Cell cycle (Georgetown, Tex.)
Published: January 22, 2024
CCR9 overexpression promotes T-ALL progression by enhancing cholesterol biosynthesis.
Journal: Frontiers in pharmacology
Published: July 12, 2023
Hematopoietic Stem and Progenitor Cells (HSPCs) and Hematopoietic Microenvironment: Molecular and Bioinformatic Studies of the Zebrafish Models.
Journal: International journal of molecular sciences
Published: June 01, 2022
TTYH3, a potential prognosis biomarker associated with immune infiltration and immunotherapy response in lung cancer.
Journal: International immunopharmacology
Published: April 28, 2022
LncRNA15691 promotes T-ALL infiltration by upregulating CCR9 via increased MATR3 stability.
Journal: Journal of leukocyte biology
Published: December 21, 2021
Recent Progress on Primary Central Nervous System Lymphoma-From Bench to Bedside.
Journal: Frontiers in oncology
Published: April 01, 2021
Targeting chemokines for acute lymphoblastic leukemia therapy.
Journal: Journal of hematology & oncology
Published: October 24, 2020
Last Updated: 09/26/2026